Question 1

What are the main differences between mirabegron and tolterodine ER?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) clinical trial (NCT02138747). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my symptoms be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) clinical trial (NCT02138747). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of for each treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) clinical trial (NCT02138747). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will the treatment last, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) clinical trial (NCT02138747). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my symptoms do not improve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) clinical trial (NCT02138747). Contact the study team or your healthcare provider for specific answers.

What this study is about